REQUEST A DEMO
Total
USD $0.00
Search more companies

Guiyang Xintian Pharmaceutical Co.,Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Guiyang Xintian Pharmaceutical Co.,Ltd. Profile Updated: November 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Guiyang Xintian Pharmaceutical Co., Ltd. is a company located in Guiyang, China. The company was established with a focus on the research, production, and sales of traditional Chinese medicine. Their main products include Kun Tai capsules, Ning Bi Tai capsules, Ku Shen gel, Xia Ku Cao oral solution, Huang Bai capsules, Tiao Jing Huo Xue capsules, Dang Gui Yi Xue oral solution, Xin Li Kang capsules, Re Lin Qing tablets, Xin Li Kang granules, Long Zhang oral solution, Cold and Cough capsules, Re Lin Qing syrup, and Xiao Yu Jiang Zhi capsules. The company has been recognized as a high-tech enterprise, a designated production enterprise for national ethnic medicine, a key leading enterprise in agricultural industrialization, and a provincial innovative enterprise. They currently hold 36 invention patents, 6 design patents, 11 national new drug certificates, and 54 drug approval numbers.

Headquarters
No. 3, Gaoxin North Road, Wudang District, Guiyang City, Guizhou Province
Guiyang; Guizhou; Postal Code: 550018

Contact Details: Purchase the Guiyang Xintian Pharmaceutical Co.,Ltd. report to view the information.

Website: http://www.gyxtyy.com

Basic Information
Total Employees:
Purchase the Guiyang Xintian Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Guiyang Xintian Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Guiyang Xintian Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Guiyang Xintian Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
August 11, 1995
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
33.89%
Purchase this report to view the information.
4.35%
Purchase this report to view the information.
2.7%
Purchase this report to view the information.
1.06%
Purchase this report to view the information.
0.87%
Subsidiaries
Beijing Kunlishu Sophora Medical Research Institute Co., Ltd.
100%
Beijing Xinwang Pharmaceutical Technology Co., Ltd.
100%
Guiyang Chengong Hotel Management Co., Ltd
100%
Company Performance
Financial values in the chart are available after Guiyang Xintian Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-14.8%
Total operating revenue
-14.8%
Operating profit (EBIT)
-32.68%
Net Profit (Loss) for the Period
-30.45%
Total assets
-5.24%
Total equity
-12.44%
Operating Profit Margin (ROS)
-2.82%
Net Profit Margin
-2.08%
Return on Equity (ROE)
-1.51%
Debt to Equity Ratio
14.94%
Quick Ratio
-0.13%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?